Connection

Jean-Charles Soria to Chemotherapy, Adjuvant

Back to Details
This is a "connection" page, showing publications Jean-Charles Soria has written about Chemotherapy, Adjuvant.
Jean-Charles Soria
Connection Strength
0.106
Chemotherapy, Adjuvant
  1. Anti-tumour effect of low molecular weight heparin in localised lung cancer: a phase III clinical trial. Eur Respir J. 2018 10; 52(4).
    View in: PubMed
    Score: 0.037
  2. Tumor Mutation Burden as a Biomarker in Resected Non-Small-Cell Lung Cancer. J Clin Oncol. 2018 10 20; 36(30):2995-3006.
    View in: PubMed
    Score: 0.036
  3. Pooled Analysis of the Prognostic and Predictive Effects of TP53 Comutation Status Combined With KRAS or EGFR Mutation in Early-Stage Resected Non-Small-Cell Lung Cancer in Four Trials of Adjuvant Chemotherapy. J Clin Oncol. 2017 Jun 20; 35(18):2018-2027.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.